Lori Anne Kunkel Sells 10,000 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel sold 10,000 shares of the firm’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $50.49, for a total value of $504,900.00. Following the transaction, the director directly owned 41,884 shares of the company’s stock, valued at $2,114,723.16. This represents a 19.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Lori Anne Kunkel also recently made the following trade(s):

• On Friday, June 5th, Lori Anne Kunkel sold 10,000 shares of Bitwise MARA Option Income Strategy ETF stock. The stock was sold at an average price of $34.54, for a total transaction of $345,400.00.

Bitwise MARA Option Income Strategy ETF Price Performance

NYSEARCA:IMRA opened at $16.78 on Friday. The firm’s 50-day moving average price is $16.94 and its 200-day moving average price is $15.57. The company has a market capitalization of $2.18 million, a PE ratio of 335.60 and a beta of 2.74. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.